title: NanOx, a new model to predict cell survival in the context of particle therapy.
abstract: Particle therapy is increasingly attractive for the treatment of tumors and the number of facilities offering it is rising worldwide. Due to the well-known enhanced effectiveness of ions, it is of utmost importance to plan treatments with great care to ensure tumor killing and healthy tissues sparing. Hence, the accurate quantification of the relative biological effectiveness (RBE) of ions, used in the calculation of the biological dose, is critical. Nevertheless, the RBE is a complex function of many parameters and its determination requires modeling. The approaches currently used have allowed particle therapy to thrive, but still show some shortcomings. We present herein a short description of a new theoretical framework, NanOx, to calculate cell survival in the context of particle therapy. It gathers principles from existing approaches, while addressing some of their weaknesses. NanOx is a multiscale model that takes the stochastic nature of radiation at nanometric and micrometric scales fully into account, integrating also the chemical aspects of radiation-matter interaction. The latter are included in the model by means of a chemical specific energy, determined from the production of reactive chemical species induced by irradiation. Such a production represents the accumulation of oxidative stress and sublethal damage in the cell, potentially generating non-local lethal events in NanOx. The complementary local lethal events occur in a very localized region and can, alone, lead to cell death. Both these classes of events contribute to cell death. The comparison between experimental data and model predictions for the V79 cell line show a good agreement. In particular, the dependence of the typical shoulders of cell survival curves on linear energy transfer are well described, but also the effectiveness of different ions, including the overkill effect. These results required the adjustment of a number of parameters compatible with the application of the model in a clinical scenario thereby showing the potential of NanOx. Said parameters are discussed in detail in this paper.
authors.affiliation: Université de Lyon, F-69622, Lyon, France. Université de Lyon 1, Villeurbanne, France. CNRS/IN2P3, Institut de Physique Nucléaire de Lyon, France.
authors.forename: M
authors.initials: M
authors.lastname: Cunha
authors.forename: C
authors.initials: C
authors.lastname: Monini
authors.forename: E
authors.initials: E
authors.lastname: Testa
authors.forename: M
authors.initials: M
authors.lastname: Beuve
mesh_terms: D000818:Animals; D002470:Cell Survival / Q000528:radiation effects*; D002478:Cells, Cultured; D006224:Cricetinae; D003412:Cricetulus; D004601:Elementary Particles / Q000627:therapeutic use*; D005347:Fibroblasts / Q000166:cytology / Q000528:radiation effects*; D018499:Linear Energy Transfer; D008168:Lung / Q000166:cytology / Q000528:radiation effects*; D008962:Models, Theoretical; D012062:Relative Biological Effectiveness